More articles from Oncology: RadioimmunoPET and Radioimmunotherapy Agents

You have access
Tumor uptake of ⁶⁴Cu-DOTA-trastuzumab correlates with HER2 gene amplification in patients with metastatic breast cancer
James Bading, Michael Press, Ivonne Villalobos, Paul Frankel, Jinha Park, Tri Tran, Mary Carroll, Erasmus Poku, Joshua Miles, David Colcher and Joanne Mortimer

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 49;
You have access
[177Lu]XYIMSR-01, a Theranostic for Targeting Carbonic Anhydrase IX
IL Minn, Hye Soo Lee, Soo Min Koo, Hye-hyun Ahn, Steven Rowe, Michael Gorin, Polina Sysa-Shah, Jae Sul, Yuchuan Wang, Sangeeta Banerjee, Ronnie Mease, Sridhar Nimmagadda, Mohamad Allaf, Martin Pomper and Xing Yang

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 53;
You have access
MUC16 Targeted Antibodies for PET Imaging of Epithelial Ovarian Carcinoma
Brandon Nemieboka, Dharmarao Thapi, Ariana Bitton and Jason Lewis

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 54;
You have access
Dual-targeting of tissue factor and CD105 for PET Imaging of Pancreatic Cancer
Haiming Luo, Christopher G. England, Sixiang Shi, Stephen A. Graves, Robert J. Nickles and Weibo Cai

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 51;
You have access
A DLL3-targeted theranostic for small cell lung cancer: Imaging a low density target with a site-specifically modified radioimmunoconjugate.
Sai Kiran Sharma, Jacob Pourat, Sean Carlin, Dalya Abdel-Atti, Alexander Bankovich, Vikram Sisodiya, David Liu, Charles Rudin, Scott Dylla, Brian Zeglis, John Poirier and Jason Lewis

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 50;
You have access
Targeted radioimmunotherapy with B7-H3-specific 212Pb-mAb 376.96 in models of human ovarian cancer.
Benjamin Kasten, Ashwini Katre, Harrison Kim, Rebecca Arend, Jinda Fan, Soldano Ferrone, Kurt Zinn and Donald Buchsbaum

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 55;
You have access
ChAcNLS-A14, a novel antibody-conjugate PET tracer for targeting human IL-5Rα-positive muscle invasive bladder cancer
Michel Paquette, Simon Beaudoin, Laurent Fafard-Couture, Luis-Guillermo Vilera-Perez, Nadia Ekindi-Ndongo, Angel Lopez, Roger Lecomte, Robert Sabbagh, Brigitte Guerin and Jeff Leyton

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 52;

Main menu

User menu

Search

More articles from Oncology: RadioimmunoPET and Radioimmunotherapy Agents